Activity of decoquinate against Cryptosporidium parvum in cell cultures and neonatal mice

Veterinary Parasitology

Volumn 89, Issue 4, 2000, Pages 307-311

  Lindsay, David S ^a   Woods, Keith M ^b   Upton, Steve J ^b   Blagburn, Byron L ^c  

^a CENTER FOR MOLECULAR MEDICINE AND INFECTIOUS DISEASES   (United States)

^b KANSAS STATE UNIVERSITY   (United States)

^c NONE

Author keywords

Cryptosporidiosis; Cryptosporidium parvum; Decoquinate; Treatment

Indexed keywords

DECOQUINATE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CATTLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CRYPTOSPORIDIOSIS; CRYPTOSPORIDIUM PARVUM; DRUG ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; MOUSE; NONHUMAN; OOCYST; SUCKLING;

ANIMALS; ANIMALS, NEWBORN; CATTLE; CELLS, CULTURED; COCCIDIOSTATS; CRYPTOSPORIDIOSIS; CRYPTOSPORIDIUM PARVUM; DECOQUINATE; DISEASE MODELS, ANIMAL; HUMANS; MICE;

BOVINAE; CRYPTOSPORIDIUM PARVUM;

EID: 0034679075     PISSN: 03044017     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-4017(00)00209-0     Document Type: Article

References (25)

1. Atwill E.R., Harp J.A., Jones T., Jardon P.W., Checel S., Zylstra M. Evaluation of periparturent dairy cows and contact surfaces as a reservoir of Cryptosporidium parvum for calfhood infection. Am. J. Vet. Res. 59:1998;1116-1121.
2. Atwill E.R., Johnson E., Klingborg D.J., Veserat G.M., Markegard G., Jensen W.A., Pratt D.W., Delmas R.E., George H.A., Forrero L.C., Philips R.L., Barry S.J., McDougald N.K., Gildersleeve R.R., Frost W.E. Age, geographic, and temporal distribution of fecal shedding of oocysts in cow-calf herds. Am. J. Vet. Res. 60:1999;420-425.
3. Bendali F., Bichet H., Schelcher F., Sanaa M. Pattern of diarrhoea in newborn beef calves in south west France. Vet. Res. 30:1999;61-74.
4. Blagburn B.L., Sundermann C.A., Lindsay D.S., Hall J.E., Tidwell R.R. Inhibition of Cryptosporidium parvum in neonatal Hsd:(ICR)BR Swiss mice by polyether ionophores and aromatic amidines. Antimicrob. Agents Chemother. 35:1991;1520-1523.
5. Blagburn B.L., Drain K.L., Land T.M., Moore P.H., Lindsay D.S., Kumar A., Shi J., Boykin D.W., Tidwell R.R. Dicationic furans inhibit development of Cryptosporidium parvum in HSD/ICR Swiss mice. J. Parasitol. 84:1998a;851-856.
6. Blagburn B.L., Drain K.L., Land T.M., Kinard R.G., Moore P.H., Lindsay D.S., Patrick D.A., Boykin D.W., Tidwell R.R. Comparative efficacy evaluation of dicationic carbazole compounds, nitazoxanide and paromomycin against Cryptosporidium parvum infections in a neonatal mouse model. Antimicrob. Agents Chemother. 42:1998;2877-2882.
7. Current, W.L., 1990. Techniques and laboratory maintenance of Cryptosporidium. In: Dubey, J.P., Speer, C.A., Fayer, R. (Eds.), Cryptosporidiosis of Man and Animals. CRC Press, Boca Raton, Florida, pp. 31-49.
8. Fry M., Williams R.B. Effects of decoquinate and clopidol on electron transport in mitochondria of Eimeria tenella (Apicomplexa: Coccidia). Biochem. Pharmacol. 33:1984;229-240.
9. Giacometti A., Cirioni O., Scalise G. In-vitro activity of macrolides alone and in combination with artemisin atovaquone dapsone minocycline or pyrimethamine against Cryptosporidium parvum. J. Antimicrob. Chemother. 38:1996;399-408.
10. Krogh H.V., Henriksen S.A. Bovine cryptosporidiosis in Denmark. 2. Cryptosporidia associated with neonatal calf diarrhea. Nord. Vet. Med. 37:1985;42-47.
11. Lindsay, D.S., Blagburn, B.L., 1995. Antiprotozoan Drugs. In: Adams, H.R. (Ed.), Veterinary Pharmacology and Therapeutics, 7th Edition. Chapter 47, pp. 955-983.
12. Lindsay D.S., Butler J.M., Blagburn B.L. Efficacy of decoquinate against Neospora caninum tachyzoites in cell cultures. Vet. Parasitol. 68:1997;35-40.
13. Lindsay D.S., Toivio-Kinnucan M.A., Blagburn B.L. Decoquinate induces tissue cyst formation by the RH strain of Toxoplasma gondii. Vet. Parasitol. 77:1998;75-81.
14. Maldonado-Camargo S., Atwill E.R., Saltijeral-Oaxaca J.A., Herrera-Alonso L.C. Prevalence of and risk factors for shedding of Cryptosporidium parvum in Holstein Freisian dairy calves in central Mexico. Prev. Vet. Med. 36:1998;95-107.
15. Mancassola R., Richard A., Naciri M. Evaluation of decoquinate to treat experimental cryptosporidiosis in kids. Vet. Parasitol. 69:1997;31-37.
16. McFadden D.C., Boothroyd J.C. Cytochrome b mutation identified in a decoquinate resistant mutant of Toxoplasma gondii. J. Euk. Microbiol. 46:1999;81s-82s.
17. Riordan C.E., Langreth S.G., Sanchez L.B., Kayser O., Keithly J.S. Preliminary evidence for a mitochondrion in Cryptosporidium parvum: phylogenetic and therapeutic implications. J. Euk. Microbiol. 46:1999;52s-53s.
18. Rohlman V.C., Kuhls T.L., Mosier D.A., Crawford D.L., Hawkins D.R., Abrams V.L., Greenfield R.A. Therapy with atovaquone for Cryptosporidium parvum infection in neonatal severe combined immunodeficiency mice. J. Infect. Dis. 168:1993;258-260.
19. Upton S.J., Gillock H.H. Infection dynamics of Cryptosporidium parvum in ICR outbred sucking mice. Folia Parasitol. 43:1996;101-106.
20. Vercesi A.E., Rodrigues C.O., Uyemura S.A., Zhong L., Moreno S.N. Respiration and oxidative phosphorylation in the apicomplexan parasite Toxoplasma gondii. J. Biol. Chem. 273:1998;31040-31047.
21. Wang C.C. Studies of the mitochondria from Eimeria tenella and inhibition of electron transport by quinolone coccidiostats. Biochem. Biophys. Acta. 396:1975;210-219.
22. Wang C.C. Inhibition of the respiration of Eimeria tenella by quinolone coccidiostats. Biochem. Pharmacol. 25:1976;343-349.
23. Woods K.M., Nesterenko M.V., Upton S.J. Development of a microtitre ELISA to quantify development of Cryptosporidium parvum in vitro. FEMS Microbiol. Lett. 128:1995;89-94.
24. Woods K.M., Nesterenko M.V., Upton S.J. Efficacy of 101 antimicrobials and other agents on the development of Cryptosporidium parvum in vitro. Ann. Trop. Med. Parasitol. 90:1996;603-615.
25. Woods K.M., Upton S.J. Efficacy of selected antiviral agents against Cryptosporidium parvum in vitro. FEMS Microbiol. Lett. 168:1998;59-63.